Print Magazine
Brussels Morning Newspaper
Sunday, January 29, 2023
No Result
View All Result
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
  • Home
    • About Us
  • EU institutions
    • Commission
    • Parliament
    • Council
  • Europe
  • World
  • Economy
  • Culture and Society
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
Brussels Morning Newspaper
No Result
View All Result
Home EU Institutions Commission

Industry representatives reassure MEPs on vaccines

Salvatore Ricci by Salvatore Ricci
23 September 2020
in Commission, Features
Industry representatives reassure MEPs on vaccines
Share on FacebookShare on Twitter

On Tuesday (22 September) the Environment, Public Health, and Food Safety Committee (ENVI) along with the Industry, Research and Energy Committee (ITRE)  held hearings with representatives of pharmaceutical companies, researchers, and civil society representatives, to review progress on the development, manufacturing process and distribution of COVID-19 vaccines. 

In its efforts to contain the spread of COVID-19 by putting in place an EU vaccine strategy. the European Commission has been negotiating agreements with pharmaceutical companies since June. By mid-August, the Commission reached an initial agreement with AstraZeneca on the procurement of a highly-promising COVID-19 vaccine. A similar advance purchase agreement has been concluded with Sanofi, which is yet to be published. Sanofi was represnted at the hearings. 

The Chairman of the ENVI Committee, Pascal Canfin (Renew Europe) asked for more transparency on the state of the research and the bvaccination contracts signed between the EC and companies. The Chairman of the ITRE Committee, Cristian Bușoi (European People’s Party), as company officials for reassurance about the efficiency and safety of the possible vaccines. 

European People’s Party MEPs expressed concern over government pressure on companies to manufacture vaccines that could compromise their safety. Socialists and Democrats Party (S&D) MEPs queried the transparency of advanced purchase agreements between the pharmaceutical companies and the European Union, demanding details about the pricing of the vaccines.

MEPs from the RENEW and the Green Party raised the issue of so-called “vaccine nationalism”, fearful that advanced purchase agreements benefit the wealthier nations while  leaving developing countries outside the immediate distribution network for the vaccines. They pointed out how the COVID-19 pandemic is a global crisis and that vaccines should therefore be considered a public health asset available to all.

The Sanofi’s representative reassured MEPs that his company’s advance purchase agreement fully respected EC tender procedures, reminding Committee members that all EU member states have the option to withdraw from the agreement if they have reservations about the vaccine’s safety. 

Sanofi and Curevac representatives affirmed their commitments to producing one billion doses in 2021. A European Medicines Agency (EMA) official reminded the hearing that “there is no vaccine 100% efficient without risk” and pointed out that the “vaccine will only be approved when the benefits outweigh the risks”.

@EU_Commission

@EMA_News

@EP_Environment

@EP_Industry

@EPP
@TheProgressives

@RenewEurope

@GreensEFA

@sanofi

@CureVacRNA

@pcanfin

@CristianSBusoi

Tags: industryVaccination
Facebook Twitter Youtube LinkedIn

About Us

Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

Category

  • Ambassador’s Corner
  • Belgium News
  • Brussels
  • Commission
  • Council
  • Culture and Society
  • Diplomacy
  • Economy
  • EU Institutions
  • Europe
  • Europe With Transparency
  • Features
  • Health & Fitness
  • In Depth
  • Member States
  • Middle East Eye
  • Opinion
  • Our pick
  • Parliament
  • Place de la Bourse
  • Southeast Europe
  • Sustainable Perspective
  • The American Angle
  • The Macro-Economist
  • Uncategorised
  • US Elections
  • World

More info

  • About Us
  • Advertising
  • Cookies Policy
  • Contact Us
  • FAQ
  • Jobs

Brussels Morning Newspaper - All Rights Reserved © 2020

No Result
View All Result
  • Home
  • About Us
  • Brussels Bubble
    • Parliament
    • Commission
    • Council
  • Wider Europe
    • Member States
  • World
  • Business & Society
  • Europe With Transparency
  • Culture & Society
  • Policy Talks
    • Place de la Bourse
    • The Macro-Economist
    • Sustainable Perspective
    • Ambassador’s Corner
    • The American Angle
    • Southeast Europe
  • Print Magazine

Brussels Morning Newspaper - All Rights Reserved © 2020

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT